HAVCR1 and atherosclerosis: However, additional studies with a larger heterogeneity regarding kidney disease and cardiovascular disease are needed to fully evaluate whether there are any clinical implications of using urinary KIM-1 for risk prediction purposes for sub-clinical atherosclerosis or future cardiovascular events.